The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England

LV Wilton, GL Pearce, RM Martin… - … Journal of Obstetrics …, 1998 - Wiley Online Library
Objective To determine the proportion and nature of congenital anomalies in babies born to
women exposed to newly marketed drugs during the first trimester. Design Non‐…

Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study

RM Martin, KV Kapoor, LV Wilton, RD Mann - Bmj, 1998 - bmj.com
Data on side effects of newly launched drugs are limited, 1 highlighting the need for effective
postmarketing surveillance. An inverted black triangle (▾) on product literature identifies …

A postmarketing surveillance study of gabapentin as add‐on therapy for 3,100 patients in England

LV Wilton, S Shakir - Epilepsia, 2002 - Wiley Online Library
Purpose: Our aim was to monitor the use of gabapentin (GBP) by patients prescribed this drug
by primary care physicians in England soon after it was marketed in the United Kingdom. …

Prescription-event monitoring and reporting of adverse drug reactions

E Heeley, J Riley, D Layton, LV Wilton, SAW Shakir - The Lancet, 2001 - thelancet.com
Newly marketed drugs in the UK are marked with a black triangle, indicating that doctors
should report all adverse drug reactions associated with them to the Committee on Safety of …

Safety of long‐term lamotrigine in epilepsy

FJ Mackay, LV Wilton, GL Peace, SN Freemantle… - …, 1997 - Wiley Online Library
: Purpose: To examine the safety of lamotrigine (LTG) used in general practice to treat
epilepsy. Methods: Information was collected on 11,316 patients who were included in a …

Prevalence of Churg–Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription‐event monitoring cohort studies

RM Martin, LV Wilton, RD Mann - … and drug safety, 1999 - Wiley Online Library
Purpose Churg–Strauss syndrome is characterised by hypereosinophilia, systemic vasculitis
and asthma. The cause is usually unknown, but there have been reports of an association …

A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies

LV Wilton, GL Pearce, RD Mann - British journal of clinical …, 1996 - Wiley Online Library
LV WILTON, GL PEARCE & RD MANN Drug Safety Research Unit, Southampton, UK … level
of confidence). Experience from early PEM studies showed that it would be informative to ask …

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

SAW Shakir, LV Wilton, A Boshier, D Layton, E Heeley - Bmj, 2001 - bmj.com
… Lynda V Wilton, senior research fellow, … Competing interests Drs Shakir and Wilton have
received financial support from Pfizer to attend conferences overseas… Articles by Lynda V Wilton

Pharmacovigilance study of alendronate in England

PN Biswas, LV Wilton, SAW Shakir - Osteoporosis international, 2003 - Springer
… could be affecting the calcium level and should be discontinued. A subsequent isotope scan
of the parathyroid gland was normal. The calcium level remained mildly raised at 2.68 mmol/…

Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study

R Kasliwal, LV Wilton, SAW Shakir - Drug Safety, 2009 - Springer
… grouped under ‘lower level’ terms, which are in turn grouped under broader ‘higher level
terms, … Lynda Wilton has no conflicts of interest to declare that are directly relevant to this study. …